Synthesis of modified mRNA for myocardial delivery

Methods in Molecular Biology

Volumn 1521, Issue , 2017, Pages 127-138

  Kondrat, Jason ^a   Sultana, Nishat ^a   Zangi, Lior ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Gene therapy; In vitro transcription; Modified mRNA; Myocardial delivery; Myocardial infarction

Indexed keywords

DNA; MESSENGER RNA; POLYTHYMIDYLIC ACID;

ANIMAL TISSUE; CARDIAC MUSCLE; CARDIOVASCULAR GENE THERAPY; CONTROLLED STUDY; DNA TEMPLATE; DNA TRANSCRIPTION; GENE DELIVERY SYSTEM; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; RNA SYNTHESIS; ANIMAL; BIOSYNTHESIS; GENE TRANSFER; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PLASMID; POLYMERASE CHAIN REACTION; PRECIPITATION; QUALITY CONTROL;

ANIMALS; CHEMICAL PRECIPITATION; GENE TRANSFER TECHNIQUES; MICE; MYOCARDIUM; PLASMIDS; POLYMERASE CHAIN REACTION; QUALITY CONTROL; RNA, MESSENGER; TEMPLATES, GENETIC; TRANSCRIPTION, GENETIC;

EID: 85005965389     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-6588-5_8     Document Type: Chapter

References (13)

1. MacLaren RE, Groppe M, Barnard AR, Cottriall CL, Tolmachova T, Seymour L, Clark KR, During MJ, Cremers FP, Black GC, Lotery AJ, Downes SM, Webster AR, Seabra MC (2014) Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial. Lancet 383(9923):1129-1137
2. Hajjar RJ, Zsebo K, Deckelbaum L, Thompson C, Rudy J, Yaroshinsky A, Ly H, Kawase Y, Wagner K, Borow K, Jaski B, London B, Greenberg B, Pauly DF, Patten R, Starling R, Mancini D, Jessup M (2008) Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure. J Card Fail 14(5):355-367
3. Schirmer JM, Miyagi N, Rao VP, Ricci D, Federspiel MJ, Kotin RM, Russell SJ, McGregor CG (2007) Recombinant adeno-associated virus vector for gene transfer to the transplanted rat heart. Transpl Int 20(6):550-557
4. Zangi L, Lui KO, von Gise A, Ma Q, Ebina W, Ptaszek LM, Spater D, Xu H, Tabebordbar M, Gorbatov R, Sena B, Nahrendorf M, Briscoe DM, Li RA, Wagers AJ, Rossi DJ, Pu WT, Chien KR (2013) Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction. Nat Biotechnol 31(10):898-907
5. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7(5):618-630
6. Lui KO, Zangi L, Chien KR (2014) Cardiovascular regenerative therapeutics via synthetic paracrine factor modified mRNA. Stem Cell Res 13(3 Pt B):693-704
7. Kormann MS, Hasenpusch G, Aneja MK, Nica G, Flemmer AW, Herber-Jonat S, Huppmann M, Mays LE, Illenyi M, Schams A, Griese M, Bittmann I, Handgretinger R, Hartl D, Rosenecker J, Rudolph C (2011) Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat Biotechnol 29(2):154-157
8. Mandal PK, Rossi DJ (2013) Reprogramming human fibroblasts to pluripotency using modified mRNA. Nat Protoc 8(3):568-582
9. Wang G, McCain ML, Yang L, He A, Pasqualini FS, Agarwal A, Yuan H, Jiang D, Zhang D, Zangi L, Geva J, Roberts AE, Ma Q, Ding J, Chen J, Wang DZ, Li K, Wang J, Wanders RJ, Kulik W, Vaz FM, Laflamme MA, Murry CE, Chien KR, Kelley RI, Church GM, Parker KK, Pu WT (2014) Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat Med 20(6): 616-623
10. Avci-Adali M, Behring A, Keller T, Krajewski S, Schlensak C, Wendel HP (2014) Optimized conditions for successful transfection of human endothelial cells with in vitro synthesized and modified mRNA for induction of protein expression. J Biol Eng 8(1):8. doi: 10.1186/1754-1611-8-8
11. Kariko K, Weissman D (2007) Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: implication for therapeutic RNA development. Curr Opin Drug Discov Devel 10(5): 523-532
12. Kariko K, Buckstein M, Ni H, Weissman D (2005) Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23(2):165-175
13. Anderson BR, Muramatsu H, Nallagatla SR, Bevilacqua PC, Sansing LH, Weissman D, Kariko K (2010) Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res 38(17):5884-5892